Michael Flamm, M.D., Ph.D.
Director of the Oupatient Hematology
THE NEW YORK-PRESBYTERIAN HOSPITAL
THE NEW YORK-PRESBYTERIAN HOSPITAL
Member of the Healthcare Council
Michael Flamm, MD, PhD, is the Director of the Outpatient Hematology Clinic at the Columbia Presbyterian campus of the New York Presbyterian Hospital. He has expertise in the treatment of sickle cell anemia and paroxysmal nocturnal hemoglobinuria, and he also treats patients with hematologic malignancies as well as solid tumors. He has consulted with companies such as Amgen in the past. (This is me - Update Profile)
| Unspecified - present | Director of the Oupatient Hematology THE NEW YORK-PRESBYTERIAN HOSPITAL |
|---|
GLG Study Groups with Michael Flamm, M.D., Ph.D.(?)
| Study Group Name | Members |
|---|---|
| Multiple Myeloma Physicians | 189 |
| Oncologists who Treat Hematologic Malignancies (US) | 881 |
| Hematologists who Treat CLL (US) | 73 |
| Physicians who Treat Multiple Myeloma (US) | 171 |
GLG NewsSM Analyses by Michael Flamm, M.D., Ph.D.(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Michael Flamm, M.D., Ph.D. has not published any public GLG News analyses.
View all GLG News in Healthcare
View all GLG News in Healthcare
GLG InstituteSM Seminars with Michael Flamm, M.D., Ph.D.(?)
Recent Seminars
Request a project with Michael Flamm, M.D., Ph.D.
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
40 of the leading 50
global mutual funds
global mutual funds
15 of the leading 20
global banks
global banks
8 of the leading 10
private equity firms
private equity firms
90%+ client subscription renewal rate